AllSeq was recently at Illumina HQ to get a sneak peek at their new NextSeq 500. We’ve already listed all of the specs and given our opinion on how we think this new platform fits into Illumina’s lineup and the broader market, but this was our first chance to see it in action. Check out our blog to see how it’s at once both tiny and huge.
Unconfigured Ad
Collapse
X
-
A first look at Illumina’s new NextSeq 500
Tags: None
-
-
We'd love to hear how it's working for you - actual outputs, how the data looks compared with previous Illumina machines. Basically anything you're willing to share! I'm sure lots of people are interested.
Comment
-
-
Using High output we are actually getting over 500 million reads per run. Unlike our GAII, and HighSeq, we actually have to pay very close attention to cluster density. The target cluster density for high quality samples is 1.75pM-2pM. Anything above and below will results in under/over clustering. So your samples need to be very exact with concentration.
These are solely made to be streamlined with the BaseSpace. Right now it only works with BaseSpace onsite, not in the cloud as they are having some majority broker issues that still are not resolved. Make sure you do your research in regards to output files and data in regards to basespace because it is not a visual machine. It gives you the output files and you must use 3rd party software on a different computer to view the results. Very annoying.
Overall very impressed with the NextSeq's, not so much BaseSapce.
Comment
-
-
We've had much the same experience as williamhorne. High Output produced roughly 500M reads, total output from a PE150 run was just shy of 150GB. We clustered at the high end of the recommended range, but still had about 80% Q30.
We've used the NextSeq with BaseSpace and it has some quirks. Run setup and sample entry is awkward if you have more than a handful of samples, although there's an option to upload an Excel file with sample info that we haven't tried yet. Never thought I'd say it, but the new run setup makes me miss Sample Sheets. On the other hand, once the run was going, BaseSpace works wonderfully.
As of right now, the NextSeq doesn't support dual indexes or custom indexes. Dual indexing is reportedly in the pipeline, not sure about custom indexes. Also, you can't start a run that exceeds the stated capacity of the reagent kit. MiSeq throws an error if you try, but it can be bypassed; NextSeq won't let you continue.
Overall, we're very happy. If read lengths get a little longer (come on, PE250!) and the BaseSpace quirks are fixed, the NextSeq will be darn close to perfect.Last edited by bryanbriney; 05-13-2014, 12:40 PM.
Comment
-
-
Does this mean you can't do more than 75 cycles in a 75 cycle kit. I confirmed with tech support that there are 25 additional cycles for dual indexing and we were told we could use those 100 cycles as we wished. We were hoping to do 47|6|47 from the 75 cycle kitOriginally posted by bryanbriney View PostAs of right now, the NextSeq doesn't support dual indexes or custom indexes. Dual indexing is reportedly in the pipeline, not sure about custom indexes. Also, you can't start a run that exceeds the stated capacity of the reagent kit. MiSeq throws an error if you try, but it can be bypassed; NextSeq won't let you continue.
Comment
-
-
I've only tried with a 300 cycle kit and the maximum number of cycles that I could perform was 308, apparently since the earliest kits only support single indexing. The error that we couldn't get past was related to the total number of cycles, and it appears that you can use those cycles however you wish -- I tried designing a run with a single 308 cycle read, and that didn't raise an error (although I didn't actually do the run).Originally posted by TonyBrooks View PostDoes this mean you can't do more than 75 cycles in a 75 cycle kit. I confirmed with tech support that there are 25 additional cycles for dual indexing and we were told we could use those 100 cycles as we wished. We were hoping to do 47|6|47 from the 75 cycle kit
Comment
-
-
I can confirm that the most you can get out of a 75 cycle kit is currently 92 cycles (76|8|8). This means you can't use the dark cycles for sequencing like you can on the MiSeq. You can register the run in BaseSpace but you get an error message when you insert the cartridge and you can't bypass it.
Comment
-
-
Do any of you have NextSeq data for something common (phiX, e.coli, mouse, etc) that you would be willing to share? Our NextSeq has consistently produced data of far lower quality than our HiSeq/MiSeq machines, and I'm trying to determine whether this is specific to the individual machine or not.
Comment
-
-
I already looked at this one: "NextSeq 500: TruSeq Nano 2x151 (PhiX)"
...and it's just as bad as ours. But thanks for the suggestion; I'll take a look at the others, as they may have used a different machine. Still, I'm kind of hoping for data from e.g. bryanbriney, as his machine seems to be producing data on-par with HiSeq machines.
Comment
-
Latest Articles
Collapse
-
by mylaserKheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
This guide explains everything you need to know about...-
Channel: Articles
Today, 01:13 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
||
|
Started by SEQadmin2, 07-02-2026, 11:08 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-02-2026, 11:08 AM
|
Comment